GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 800 shares, a decrease of 98.6% from the January 15th total of 58,800 shares. Based on an average daily volume of 5,800 shares, the short-interest ratio […]
GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 66,800 shares, an increase of 14.8% from the November 30th total of 58,200 shares. Based on an average trading volume of 118,800 shares, the days-to-cover ratio is currently 0.6 […]
GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) was the target of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 132,900 shares, a decline of 16.8% from the October 15th total of 159,800 shares. Based on an average daily volume of 147,900 shares, […]
GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) saw a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 102,200 shares, a growth of 122.2% from the September 15th total of 46,000 shares. Based on an average daily trading volume, of 265,000 shares, the short-interest […]
GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report)’s share price dropped 5.4% during trading on Wednesday . The company traded as low as $0.29 and last traded at $0.30. Approximately 109,688 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 303,826 shares. The stock had previously closed at […]